Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
Akhilesh SwaminathanGrace M BorichevskyTeagan S EdwardsEsther HirschfeldThomas C MulesChris M A FramptonAndrew S DayMark B HamptonAnthony J KettleRichard B GearryPublished in: Journal of Crohn's & colitis (2022)
Faecal myeloperoxidase is an accurate biomarker of endoscopic activity in IBD and predicted a more complicated IBD course during follow-up.